MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Deep brain stimulation (DBS)"

  • 2019 International Congress

    One-year follow-up of subthalamic deep brain stimulation in Parkinson’s disease

    L. Barcelos, M. Tosin, M. Marinho, C. Silva, R. Saba, S. Silva, V. Borges, H. Ferraz (Sao Paulo, Brazil)

    Objective: To report the results of one-year follow-up of subthalamic deep brain stimulation in Parkinson's disease on 19 patients bilaterally implanted at Federal University of…
  • 2019 International Congress

    PPN-GAB-PARK: Short time outcome and long term follow up in PPN-DBS

    C. Giordana, M. Borg, JP. Flambart, J. Bredin, D. Fontaine (Nice, France)

    Objective: To report the short and long term outcome of bilateral PPN DBS. Background: Deep brain stimulation (DBS) of peducolopontin nucleus (PPN) has been proposed…
  • 2019 International Congress

    Directional Deep Brain Stimulation Lead Implantation: A Single Center Experience

    R. Kochanski, A. Borghei, G. Pal, L. Verhagen Metman, F. Lynn, J. Karl, S. Sani (Chicago, IL, USA)

    Objective: The authors’ experience with implantation of the first 100 patients implanted with Abbott St. Jude Medical Infinity™ DBS lead system. Background: The introduction of…
  • 2019 International Congress

    Dopamine dysregulation syndrome and levodopa-induced dyskinesias in patients with Parkinson’s disease on the background of deep stimulation of the subthalamic nucleus

    S. Omarova, N. Fedorova, A. Tomskiy, A. Gamaleya, E. Bril (Moscow, Russian Federation)

    Objective: Assessment of the dynamics of the clinical manifestations of dofamine dysregulation syndrome (DDS)  and the severity of dyskinesias in patients with Parkinson`s Disease (PD)…
  • 2019 International Congress

    Effect of global cognitive score on motor and quality of life outcomes after deep brain stimulation in patients with Parkinson’s disease or essential tremor

    E. Staikova, D. Loring, M. Delong, S. Triche, C. Buetefisch, C. Esper, T. Wichmann, L. Scorr, L. Higginbotham, P. Aia, S. Factor, S. Miocinovic (Atlanta, GA, USA)

    Objective: To determine if preoperative global cognitive score, Mattis Dementia Rating Scale 2nd Edition (DRS-2), predicts motor and quality of life (QoL) outcomes in patients…
  • 2019 International Congress

    Management of life threatening dyskinesias in GNAO1 related movement disorder: two new cases and review of the literature

    M. Hull, M. Parnes (Houston, TX, USA)

    Objective: To present two cases of GNAO1 related movement disorder associated with life threatening persistent chorea successfully managed with bilateral GPi deep brain stimulation (GPi-DBS)…
  • 2019 International Congress

    Predicting the efficacy of STN-DBS in patients with different Parkinson’s disease motor subtypes by preoperative total and partial levodopa response

    GH. Lu, ZX. Yin, YW. Jin (Nanchang, China)

    Objective: To better investigate the value of the challenge test by introducing total and partial LR, and explain the clinical significance of 30% LR through…
  • 2019 International Congress

    INTREPID: A 2-Year Follow-Up of a Prospective, Double Blinded, Multi-Center Randomized Controlled Trial Evaluating Deep Brain Stimulation with a New Multiple Source, Constant-Current Rechargeable System for Treatment of Parkinson’s Disease

    J. Vitek, R. Jain, L. Chen, I. Study Group, P. Starr (Minneapolis, MN, USA)

    Objective: The objective of the INTREPID clinical trial assessed improvement in motor function and quality of life in patients with advanced, levodopa responsive Parkinson's disease…
  • 2019 International Congress

    Left STN DBS And Right CZI DBS In A Patient With Tremor-Predominant Parkinson’s Disease

    T. Ali, D. Ginjupally, G. Quintero, C. van Horne, Z. Guduru (Lexington, KY, USA)

    Objective: We report a 65-year-old-man with tremor-predominant PD who had left subthalamic nucleus (STN) DBS and right CZi DBS for tremor control. Background: Deep brain…
  • 2019 International Congress

    Can the Quantified Timed Up and Go (QTUG) device support decision making for patients undergoing Deep Brain Stimulation?

    J. Somerset, B. Hammersley, M. Bonello (Liverpool, United Kingdom)

    Objective: To increase the speed and objectivity of decision making for patients with Parkinson’s disease and gait impairments, undergoing deep brain stimulation (DBS), using the…
  • « Previous Page
  • 1
  • …
  • 90
  • 91
  • 92
  • 93
  • 94
  • …
  • 152
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • An atypical and interesting feature of Parkinson´s disease
      • A Case of Pregabalin induced Parkinsonism
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley